摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-(三氟乙酰基)-8-氮杂双环[3.2.1]辛烷-3-酮 | 176910-42-2

中文名称
8-(三氟乙酰基)-8-氮杂双环[3.2.1]辛烷-3-酮
中文别名
——
英文名称
N-trifluoroacetylnortropinone
英文别名
8-(2,2,2-trifluoro-acetyl)-8-aza-bicyclo[3.2.1]octan-3-one;8-(2,2,2-Trifluoroacetyl)-8-aza-bicyclo[3.2.1]octan-3-one;N-trifluoroacetyl-nortropinone;8-Trifluoroacetyl-8-azabicyclo[3.2.1]octan-3-one;8-(2,2,2-trifluoroacetyl)-8-azabicyclo[3.2.1]octan-3-one
8-(三氟乙酰基)-8-氮杂双环[3.2.1]辛烷-3-酮化学式
CAS
176910-42-2
化学式
C9H10F3NO2
mdl
——
分子量
221.179
InChiKey
VQAKWLUSFTURKR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.78
  • 拓扑面积:
    37.4
  • 氢给体数:
    0
  • 氢受体数:
    5

SDS

SDS:4d31c08df366909f3e2ac1382ec5edf1
查看

反应信息

  • 作为反应物:
    描述:
    8-(三氟乙酰基)-8-氮杂双环[3.2.1]辛烷-3-酮三氟化硼乙醚potassium carbonate 作用下, 以 二氯甲烷 为溶剂, 生成 methyl <(2SR,5RS)-(E)-N-trifluoroacetyl-5-styrylpiperidin-2-yl>acetate
    参考文献:
    名称:
    Ring Cleavage Reaction of Heterocyclic Ketones Based on Crossed Aldol Condensation
    摘要:
    Ring cleavage reaction based on crossed aldol condensation using heterocyclic ketones such as 4-piperidone and nortropinone derivatives with benzaldehyde under acetalization conditions (BF3 . Et(2)O/ethylene glycol) has been achieved.
    DOI:
    10.3987/com-95-7339
  • 作为产物:
    描述:
    去甲托品酮三氟乙酸酐吡啶 作用下, 以 二氯甲烷 为溶剂, 反应 24.0h, 以49%的产率得到8-(三氟乙酰基)-8-氮杂双环[3.2.1]辛烷-3-酮
    参考文献:
    名称:
    Ring Cleavage Reaction of Heterocyclic Ketones Based on Crossed Aldol Condensation
    摘要:
    Ring cleavage reaction based on crossed aldol condensation using heterocyclic ketones such as 4-piperidone and nortropinone derivatives with benzaldehyde under acetalization conditions (BF3 . Et(2)O/ethylene glycol) has been achieved.
    DOI:
    10.3987/com-95-7339
  • 作为试剂:
    参考文献:
    名称:
    TRICYCLIC-BRIDGED PIPERIDINYLIDENE DERIVATIVES AS DELTA OPIOID MODULATORS
    摘要:
    本发明涉及用于治疗各种疾病和病症,包括疼痛的化合物、组合物和方法。这些化合物由以下式子I表示:其中A、G、Y、R3、R4和R5在此被定义。
    公开号:
    US20090291979A1
点击查看最新优质反应信息

文献信息

  • [EN] HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS<br/>[FR] AMIDES DE CHROMÈNE HÉTÉROCYCLIQUE-PIPÉRIDINE SPIROCYCLIQUE UTILES COMME MODULATEURS DES CANAUX IONIQUES
    申请人:VERTEX PHARMA
    公开号:WO2011140425A1
    公开(公告)日:2011-11-10
    The invention relates to heterocyclic chromene-spirocyclic piperidine amides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
    本发明涉及杂环色烯-螺环哌啶酰胺,用作离子通道的抑制剂。本发明还提供了包含本发明化合物的药用可接受组合物,以及使用这些组合物治疗各种疾病的方法。
  • [EN] BENZOXAZINES AS MODULATORS OF ION CHANNELS<br/>[FR] BENZOXAZINES COMME MODULATEURS DES CANAUX IONIQUES
    申请人:VERTEX PHARMA
    公开号:WO2013067248A1
    公开(公告)日:2013-05-10
    The invention relates to benzoxazines useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
    本发明涉及可用作离子通道抑制剂的苯并噁嗪。本发明还提供了包含本发明化合物的药用可接受组合物,以及使用这些组合物治疗各种疾病的方法。
  • Tricyclic delta-opioid modulators
    申请人:Dax Scott
    公开号:US20060030585A1
    公开(公告)日:2006-02-09
    The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.
    这项发明涉及δ阿片受体调节剂。更具体地,该发明涉及三环δ-阿片调节剂。还描述了利用该发明的化合物治疗轻度至严重疼痛和各种疾病的药用和兽医组合物以及方法。
  • TRICYCLIC OPIOID MODULATORS
    申请人:DeCorte Bart
    公开号:US20060287297A1
    公开(公告)日:2006-12-21
    The invention is directed to compounds of Formula (I) useful as delta and mu opioid receptor modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.
    该发明涉及一种具有式(I)的化合物,可用作δ和μ阿片受体调节剂。还描述了使用该发明的化合物治疗轻度至严重疼痛和各种疾病的药物和兽医组合物及方法。
  • HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS
    申请人:Hadida-Ruah Sara Sabina
    公开号:US20110306607A1
    公开(公告)日:2011-12-15
    The invention relates to heterocyclic chromene-spirocyclic piperidine amides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
    本发明涉及杂环色烯-螺环哌啶酰胺类化合物,其可用作离子通道抑制剂。本发明还提供了包含本发明化合物的药学上可接受的组合物,并提供了使用这些组合物治疗各种疾病的方法。
查看更多